Akums Drugs (AKUMS)

FAST GROWER

FairStock Score: 70/100 — STEADY

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹539.2
Market Cap₹7,683.19 Cr
P/E Ratio23.68
ROCE16.2%
ROE10.44%
Dividend Yield0%
Profit Growth113.21%
Debt/Equity0.03
Sales Growth6.24%
Free Cash Flow₹-8,264 Cr
Promoter Holding75.26%
52-Week Range₹409.3 — ₹633.55
SectorPharmaceuticals & Biotechnology
Book Value₹193.59

Akums Drugs trades with a P/E ratio of 23.68, ROCE of 16.2%, ROE of 10.44%, profit growth of 113.21%, debt-to-equity of 0.03. The FairStock Score of 70/100 reflects strong fundamentals across multiple dimensions.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer